Merians Alma S, Fluet Gerard G, Qiu Qinyin, Yarossi Mathew, Patel Jigna, Mont Ashley J, Saleh Soha, Nolan Karen J, Barrett A M, Tunik Eugene, Adamovich Sergei V
Department of Rehabilitation and Movement Sciences, School of Health Professions, Rutgers Biomedical and Health Sciences, Newark, NJ, United States.
Movement Neuroscience Laboratory, Department of Physical Therapy, Movement and Rehabilitation Science, Bouve College of Health Sciences, Northeastern University, Boston, MA, United States.
Front Neurol. 2020 Nov 26;11:573642. doi: 10.3389/fneur.2020.573642. eCollection 2020.
Innovative motor therapies have attempted to reduce upper extremity impairment after stroke but have not made substantial improvement as over 50% of people post-stroke continue to have sensorimotor deficits affecting their self-care and participation in daily activities. Intervention studies have focused on the role of increased dosing, however recent studies have indicated that timing of rehabilitation interventions may be as important as dosing and importantly, that dosing and timing interact in mediating effectiveness. This study is designed to empirically test dosing and timing. In this single-blinded, interventional study, subjects will be stratified on two dimensions, impairment level (Fugl-Meyer Upper Extremity Assessment (FM) and presence or absence of Motor Evoked Potentials (MEPs) as follows; (1) Severe, FM score 10-19, MEP+, (2) Severe, FM score 10-19, MEP-, (3) Moderate, FM score 20-49, MEP+, (4) Moderate, FM score 20-49, MEP-. Subjects not eligible for TMS will be assigned to either group 2 (if severe) or group 3 (if moderate). Stratified block randomization will then be used to achieve a balanced assignment. Early Robotic/VR Therapy (EVR) experimental group will receive in-patient usual care therapy plus an extra 10 h of intensive upper extremity therapy focusing on the hand using robotically facilitated rehabilitation interventions presented in virtual environments and initiated 5-30 days post-stroke. Delayed Robotic/VR Therapy (DVR) experimental group will receive the same intervention but initiated 30-60 days post-stroke. Dose-matched usual care group (DMUC) will receive an extra 10 h of usual care initiated 5-30 days post-stroke. Usual Care Group (UC) will receive the usual amount of physical/occupational therapy. There are clinical, neurophysiological, and kinematic/kinetic measures, plus measures of daily arm use and quality of life. Primary outcome is the Action Research Arm Test (ARAT) measured at 4 months post-stroke. Outcome measures will be assessed to determine whether there is an early time period in which rehabilitation will be most effective, and whether there is a difference in the recapture of premorbid patterns of movement vs. the development of an efficient, but compensatory movement strategy. The IRBs of New Jersey Institute of Technology, Rutgers University, Northeastern University, and Kessler Foundation reviewed and approved all study protocols. Study was registered in https://ClinicalTrials.gov (NCT03569059) prior to recruitment. Dissemination will include submission to peer-reviewed journals and professional presentations.
创新运动疗法试图减轻中风后的上肢功能障碍,但尚未取得实质性进展,因为超过50%的中风患者仍存在感觉运动缺陷,影响其自我护理和参与日常活动。干预研究主要集中在增加治疗剂量的作用上,然而最近的研究表明,康复干预的时机可能与剂量同样重要,而且重要的是,剂量和时机在调节疗效方面相互作用。本研究旨在通过实证检验剂量和时机。在这项单盲干预研究中,受试者将在两个维度上进行分层,即损伤水平(Fugl-Meyer上肢评估(FM))和运动诱发电位(MEP)的有无,具体如下:(1)重度,FM评分10-19,MEP阳性;(2)重度,FM评分10-19,MEP阴性;(3)中度,FM评分20-49,MEP阳性;(4)中度,FM评分20-49,MEP阴性。不符合经颅磁刺激(TMS)条件的受试者将被分配到第2组(如果是重度)或第3组(如果是中度)。然后采用分层区组随机化来实现均衡分配。早期机器人/虚拟现实疗法(EVR)实验组将接受住院常规护理治疗,外加10小时的强化上肢治疗,重点是使用虚拟环境中呈现的机器人辅助康复干预措施对手部进行治疗,并在中风后5-30天开始。延迟机器人/虚拟现实疗法(DVR)实验组将接受相同的干预,但在中风后30-60天开始。剂量匹配常规护理组(DMUC)将在中风后5-30天开始接受额外10小时的常规护理。常规护理组(UC)将接受常规量的物理/职业治疗。有临床、神经生理学和运动学/动力学测量指标,以及日常手臂使用情况和生活质量的测量指标。主要结局是中风后4个月时测量的行动研究臂测试(ARAT)。将评估结局指标,以确定是否存在康复最有效的早期时间段,以及在恢复病前运动模式与发展高效但代偿性运动策略方面是否存在差异。新泽西理工学院、罗格斯大学、东北大学和凯斯勒基金会的机构审查委员会审查并批准了所有研究方案。研究在招募前已在https://ClinicalTrials.gov(NCT03569059)注册。传播将包括提交给同行评审期刊和专业报告。